Cart
Rx Abbott India Mfg: Bharat Biotech Cold Chain Typhoid Vi Conjugate
Enteroshield 0.5 Typhoid Vi Conjugate Vaccine IP by Abbott India - Box Front

Enteroshield - Abbott India - 0.5 mL Single Dose PFS - Intramuscular Use Only

Enteroshield composition label - Vi Polysaccharide conjugated to Tetanus Toxoid 25mcg

Composition - Storage 2-8C - Mfd by Bharat Biotech - Marketed by Abbott India - Verified by VacciHub

Enteroshield 0.5 - Typhoid Vi Conjugate Vaccine IP

Full Name: Typhoid Vi Conjugate Vaccine I.P.
Brand: Enteroshield 0.5  |  Marketed by: Abbott India Limited  |  Manufactured by: Bharat Biotech International Limited, Hyderabad  |  Pack: 0.5 mL Single Dose PFS  |  Route: Intramuscular Only

Abbott India Brand Cold Chain Assured Certified Nurse Bharat Biotech Mfg. From 6 Months
Enteroshield 0.5 is a Typhoid Vi Conjugate Vaccine IP (TCV) marketed by Abbott India Limited and manufactured by Bharat Biotech International Limited. Each 0.5 mL prefilled syringe contains purified Vi Capsular Polysaccharide of Salmonella typhi Ty2 conjugated to Tetanus Toxoid (25 μg). It generates durable T-cell-dependent immunity against typhoid fever, effective from 6 months of age - a major advantage over older unconjugated polysaccharide typhoid vaccines.
Marketed by Abbott India Limited Bhiwandi, Maharashtra
Manufactured by Bharat Biotech Intl. Ltd. Genome Valley, Hyderabad
Pack Size 0.5 mL PFS Single Dose
Storage +2C to +8C Do NOT Freeze

What is Typhoid and Why Vaccinate?

🌡

Typhoid Fever

A life-threatening systemic infection caused by Salmonella typhi. Spreads via contaminated food and water. Causes sustained high fever, severe headache, abdominal pain and can progress to intestinal perforation or sepsis if untreated.

🇮🇳

India's High Burden

India reports an estimated 4-6 million typhoid cases per year. Delhi NCR, Noida and Ghaziabad are high-risk zones due to population density and variable sanitation. Children aged 2-15 bear the highest burden.

💊

Drug Resistance (XDR Typhoid)

Extensively Drug-Resistant (XDR) typhoid resistant to multiple antibiotics is spreading rapidly. Vaccination with TCV is now the most reliable and cost-effective prevention strategy against even drug-resistant strains.

🛡️

Why TCV is the Gold Standard

Conjugate technology (Vi + Tetanus Toxoid) generates T-cell memory - protection from 6 months, longer duration, booster effect on re-exposure. WHO recommends TCV over plain polysaccharide vaccines globally.

Who Should Get Enteroshield 0.5?

👶

Infants from 6 Months

Enteroshield can be given from 6 months of age - unlike older typhoid vaccines limited to 2 years+. IAP recommends first dose at 9-12 months for routine vaccination.

👧👦

Children 1-15 Years

Highest-risk age group for typhoid in India. Single dose provides strong protection. Booster at 2 years if primary dose was given before 2nd birthday.

✈️

Pre-Travel Vaccination

Travelling to typhoid-endemic areas - South Asia, Southeast Asia, Sub-Saharan Africa. Book Enteroshield at home 2 or more weeks before departure with VacciHub.

👨‍💼

Adults in High-Risk Areas

Adults in Delhi NCR with unreliable water supply, food handlers, sanitation workers and healthcare staff dealing with enteric fever cases.

🔬

Microbiology Lab Workers

Occupational exposure to Salmonella typhi. Typhoid vaccination is recommended in microbiology and reference laboratories per occupational health guidelines.

🏥

Immunocompromised Individuals

HIV-positive, transplant patients and those on immunosuppressive therapy face higher typhoid risk. Consult your doctor - TCV is generally recommended with appropriate caution.

Enteroshield Composition - Per 0.5 mL Dose

As per Abbott India / Bharat Biotech manufacturer label. Each 0.5 mL PFS contains:

ComponentQuantityNotes
ACTIVE INGREDIENT
Purified Vi Capsular Polysaccharide of Salmonella typhi Ty2 25 μg Conjugated to Tetanus Toxoid - T-cell dependent response
CARRIER PROTEIN
Tetanus Toxoid 25 μg Carrier protein - drives immunological memory via T-helper cells
EXCIPIENTS
Sodium Chloride I.P.4.5 mgTonicity agent
Water for Injections I.P.q.s. to 0.5 mLVehicle
Same core formulation as Typbar TCV. Enteroshield uses the identical active ingredient - Vi polysaccharide (25 μg) conjugated to Tetanus Toxoid (25 μg) - as Bharat Biotech's own Typbar TCV brand. The difference is branding and marketing partner (Abbott India for Enteroshield vs Bharat Biotech directly for Typbar TCV).
Storage critical: Store at +2C to +8C. Do NOT freeze - discard if frozen. Shake well before use. VacciHub nurses carry Enteroshield in validated cold boxes and verify the Vaccine Vial Monitor indicator before every dose.

Enteroshield - IAP 2024 Vaccination Schedule

GroupDoseAge / TimingNotes
Infants (routine) 1 Dose 9-12 months IAP extended immunisation schedule
Booster (if under 2 yrs at 1st dose) Booster 2 years of age Required if primary dose given before 2nd birthday
Children 2-15 yrs (catch-up) 1 Dose Any time Repeat every 3 years in high-risk areas
Adults 1 Dose Any time Repeat every 3 years if continued risk
Pre-travel 1 Dose 2 or more weeks before travel Endemic regions: South Asia, Africa, Southeast Asia
Min age 6 months. Enteroshield is approved from 6 months - the standard first dose per IAP is at 9-12 months alongside other vaccines. Children previously vaccinated with plain Vi polysaccharide vaccine may switch to TCV for improved protection.

How Does Enteroshield Work?

1
Vi-Tetanus Toxoid Conjugate Injected IM The 0.5 mL PFS delivers purified Vi polysaccharide (25 μg) covalently conjugated to Tetanus Toxoid (25 μg). Administered deep intramuscularly - deltoid in adults/older children, anterolateral thigh in infants.
2
T-Cell Help via Tetanus Toxoid Carrier The Tetanus Toxoid carrier protein presents the Vi polysaccharide to T-helper cells, converting the immune response from T-independent to T-dependent. This is the critical difference - plain Vi polysaccharide vaccines cannot engage T-cells and thus generate no immunological memory.
3
High-Titre Anti-Vi IgG Antibodies and Memory The immune system generates robust IgG antibodies against Vi capsular polysaccharide - these coat S. typhi bacteria and enable complement-mediated killing and phagocytosis. Long-lived memory B and T-cells are simultaneously created.
4
Effective from 6 Months - Lasts Years Protection develops in about 2 weeks. Conjugate technology enables effective vaccination from 6 months - when plain polysaccharide vaccines are completely ineffective. Booster recommended every 3 years for high-risk individuals.

Enteroshield Side Effects

Enteroshield has a strong safety profile. No aluminium adjuvant, no preservatives - one of the cleanest typhoid vaccine formulations available.

Common (Mild, Self-Limiting)
  • Injection-site pain / tenderness
  • Redness or swelling at site
  • Low-grade fever (under 38.5C)
  • Irritability / crying (infants)
  • Mild fatigue / drowsiness
Rare - Seek Medical Attention
  • High fever (over 39C)
  • Prolonged crying over 3 hours (infants)
  • Extensive limb swelling
  • Anaphylaxis (extremely rare)
Apply a cool cloth (not ice) to injection site. Paracetamol may be used for fever/pain per doctor's advice. Observe for 30 minutes post-vaccination - our VacciHub nurses stay and monitor before leaving.

Enteroshield vs Typbar TCV - What's the Difference?

Both are Typhoid Vi Conjugate Vaccines from the same manufacturer. Here's how they compare:

FeatureEnteroshieldTypbar TCV
Marketed byAbbott India LimitedBharat Biotech (own brand)
Manufactured byBharat Biotech Intl. Ltd.Bharat Biotech Intl. Ltd.
Active IngredientVi Polysaccharide 25 μg + TT 25 μgVi Polysaccharide 25 μg + TT 25 μg
FormulationIdenticalIdentical
Min Age6 months6 months
No AluminiumCorrectCorrect
No PreservativesCorrectCorrect
Brand BackingAbbott India (global healthcare major)Bharat Biotech (domestic leader)
Bottom line: Enteroshield and Typbar TCV are effectively the same vaccine - same manufacturer, same active ingredients, same formulation. Enteroshield is simply Bharat Biotech's TCV platform marketed through Abbott India's distribution network. Your doctor or VacciHub nurse can advise on availability.

Precautions and Contraindications

Do NOT give Enteroshield if:

  • Known hypersensitivity to any component, including Tetanus Toxoid
  • Severe allergic reaction to a prior TCV or Vi vaccine dose
  • Acute febrile illness on vaccination day - defer until recovery

Use with Caution:

  • Immunosuppressed individuals - immune response may be reduced; still recommended
  • Pregnancy - consult doctor; benefit generally outweighs risk for endemic area residents or travellers
  • Recent Tetanus Toxoid-containing vaccine - discuss timing with doctor
  • Thrombocytopenia or coagulation disorders - injection-site bleeding risk
Never freeze. Freezing irreversibly destroys Enteroshield's efficacy. Check the Vaccine Vial Monitor before use - VacciHub nurses are trained on cold chain verification at every home visit.

Why Book Enteroshield with VacciHub?

👩‍⚕️

Certified Nursing Staff

Trained, certified nurses with paediatric and adult vaccination experience. Correct deep IM technique for every age group.

❄️

Cold Chain - Never Frozen

Enteroshield must NEVER be frozen. Our validated cold boxes maintain exactly 2-8C. Potency guaranteed from warehouse to your arm.

100% Genuine Abbott / Bharat Biotech

Sourced from authorised distributors only. Batch numbers, MFG and EXP dates fully transparent and verifiable.

🏠

Home Comfort

No hospital trips, no queues. Our nurse comes to you - especially convenient for infants, toddlers and busy working families.

📋

Digital Vaccination Record

Batch number, expiry, dose details shared via WhatsApp post-visit. Booster reminders set automatically.

🕐

Same-Day and Weekend Slots

Flexible bookings morning to evening including weekends. Pre-travel at short notice? Same-day available across Delhi NCR.

Enteroshield Home Vaccination - Cities We Cover

🏛️Delhi (All Areas)
🏙️Gurgaon
🌅Noida
🏠Ghaziabad
🏗️Faridabad
🌚Greater Noida

Call +91 92050 04114 to confirm your pincode. Same-day slots available.

Frequently Asked Questions - Enteroshield Vaccine

Enteroshield is a Typhoid Vi Conjugate Vaccine IP (TCV) marketed by Abbott India Limited and manufactured by Bharat Biotech International Limited, Hyderabad. It contains purified Vi Capsular Polysaccharide of Salmonella typhi Ty2 conjugated to Tetanus Toxoid (25 μg), providing T-cell-dependent immunity against typhoid fever from 6 months of age.

Copyright © All Rights Reserved VacciHub by PSTRIDE SOLUTIONS LLP